HDAC inhibitors (East China University of Science and Technology/Fudan/Guangxi/Northeastern/Sichuan University/Harvard Medical School)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameHDAC inhibitors (East China University of Science and Technology/Fudan/Guangxi/Northeastern/Sichuan University/Harvard Medical School)
Drug Alias NameM-344
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase inhibitors
TargetsHistone deacetylase
Therapy Area/IndicationsIdiopathic Pulmonary FibrosisAcute Lung Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesEast China University Of Science And Technology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGuangxi UniversityNortheastern UniversityFudan University +[6] 
Active IndicationsN/A
Inactive IndicationsIdiopathic Pulmonary FibrosisAcute Lung Injury

Other Information

ATC CodeN/A
Related LinksN/A